| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.6 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.6 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |